215 related articles for article (PubMed ID: 7909240)
1. Review article: the use of gastric acid-inhibitory drugs--physiological and pathophysiological considerations.
Waldum HL; Brenna E; Kleveland PM; Sandvik AK; Syversen U
Aliment Pharmacol Ther; 1993 Dec; 7(6):589-96. PubMed ID: 7909240
[TBL] [Abstract][Full Text] [Related]
2. [Optimal use of acid-inhibitors in acid-related diseases. Physiological and physiopathological considerations with implications on therapeutic choice].
Waldum HL
Tidsskr Nor Laegeforen; 1993 Feb; 113(4):465-9. PubMed ID: 8465291
[TBL] [Abstract][Full Text] [Related]
3. Histamine H2-receptor antagonists and gastric acid secretion.
Pounder RE
Pharmacol Ther; 1984; 26(2):221-34. PubMed ID: 6152495
[No Abstract] [Full Text] [Related]
4. Marked increase in gastric acid secretory capacity after omeprazole treatment.
Waldum HL; Arnestad JS; Brenna E; Eide I; Syversen U; Sandvik AK
Gut; 1996 Nov; 39(5):649-53. PubMed ID: 9026477
[TBL] [Abstract][Full Text] [Related]
5. Histamine H2-receptor antagonists.
Feldman M; Richardson CT
Adv Intern Med; 1978; 23():1-24. PubMed ID: 24327
[TBL] [Abstract][Full Text] [Related]
6. [Drug treatment of reflux esophagitis: effects of strong gastric acid inhibition].
Jansen JB; Lamers CB
Ned Tijdschr Geneeskd; 1989 Apr; 133(13):662-5. PubMed ID: 2566126
[No Abstract] [Full Text] [Related]
7. [Which drug for peptic ulcer?].
Hameeteman W; Tytgat GN
Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
[No Abstract] [Full Text] [Related]
8. Appropriate acid suppression in the treatment of acid-related conditions.
Howden CW
Pharmacol Ther; 1994; 63(1):123-34. PubMed ID: 7972343
[TBL] [Abstract][Full Text] [Related]
9. Peptic ulcer disease: physiology and pathophysiology.
Holt KM; Isenberg JI
Hosp Pract (Off Ed); 1985 Jan; 20(1):89-93, 96-101, 104-6. PubMed ID: 2856923
[No Abstract] [Full Text] [Related]
10. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H
J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516
[TBL] [Abstract][Full Text] [Related]
11. [Anti-ulcer drugs. Indications in adults. French Agency of the Safety of Health Products].
Presse Med; 2000 Jan; 29(2):86-94. PubMed ID: 10682037
[No Abstract] [Full Text] [Related]
12. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
Simon B; Müller P; Dammann HG
Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
[TBL] [Abstract][Full Text] [Related]
13. [Lansoprazol].
Ponce J; Nos P
Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
[No Abstract] [Full Text] [Related]
14. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
McTavish D; Buckley MM; Heel RC
Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of gastric acid secretion: advantages and risks in short and long-term treatment.
Mazzacca G; Sabbatini F
Ital J Gastroenterol; 1990; 22 Suppl 1():11-2. PubMed ID: 1983419
[TBL] [Abstract][Full Text] [Related]
16. [Acid anti-secretion therapy in gastric and duodenal ulcer].
Lattanzi A
Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184
[No Abstract] [Full Text] [Related]
17. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
Gorshkov VA
Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
[No Abstract] [Full Text] [Related]
18. Control of gastric acid secretion in health and disease.
Schubert ML; Peura DA
Gastroenterology; 2008 Jun; 134(7):1842-60. PubMed ID: 18474247
[TBL] [Abstract][Full Text] [Related]
19. Reversible sustained increase of gastrin and gastric acid secretion in a subgroup of duodenal ulcer patients on long-term treatment with H2 antagonists.
Kohn A; Annibale B; Prantera C; Giglio L; Suriano G; Delle Fave G
J Clin Gastroenterol; 1991 Jun; 13(3):284-90. PubMed ID: 1676714
[TBL] [Abstract][Full Text] [Related]
20. Is hypergastrinaemia dangerous to man?
Creutzfeldt W; Lamberts R
Scand J Gastroenterol Suppl; 1991; 180():179-91. PubMed ID: 1675024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
